Skip to main content

Table 1 Baseline patient characteristics

From: Low dose Naltrexone for induction of remission in inflammatory bowel disease patients

General characteristics
 Diagnosis, N (%) UC, 19 (40%) CD, 28 (60%) Combined, 47
 Gender (M/F) 10/9 9/19 19/28
 Median age at diagnosis (years, IQR) 31 (27–44.5) 23 (16.8–32.5) 27 (18–39.5)
 Median age at start of LDN (years, IQR) 42 (33.5–52) 35.5 (25.5–53.5) 40 (27.5–52.5)
 Median disease duration at start of LDN (years, IQR) 6.9 (3.2–12.4) 7.8 (3.8–16.5) 7.0 (3.8–13.4)
 CRP mg/L, median (IQR) 7 (2–27) 6 (2–7) 6 (2–9)
 Endoscopic score (median, IQR) 2.0 (1.0–2.0) 2.0 (2.0–2.0) 2.0 (1.25–2.0)
Disease characteristics
 Disease extent or phenotype [montreal classification, % (N)] E1 11% (2) L1 7% (2)  
E2 63% (12) L2 32% (9)
E3 26% (5) L3 61% (17)
  1. CD Crohn’s disease, CRP C-reactive protein, IQR inter-quartile range, LDN low dose Naltrexone, UC ulcerative colitis